NTRK

Clinical trials for NTRK explained in plain language.

Never miss a new study

Get alerted when new NTRK trials appear

Sign up with your email to follow new studies for NTRK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets Hard-to-Treat cancers with specific genetic flaw

Disease control Recruiting now

This early-stage trial is testing a new oral drug called CG001419 for adults with advanced solid tumors that have specific changes in the NTRK gene and have stopped responding to standard treatments. The study first aims to find a safe and effective dose, then see if the drug can…

Matched conditions: NTRK

Phase: PHASE1, PHASE2 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NTRK

Get alerted when new NTRK trials appear

New pill targets Hard-to-Treat cancers with specific genetic flaw